Tagapan, Letty B.
HRN: 24 43 84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/16/2024
01/22/2024
IV INFUSION
1.5gm
Q6
Non Healing Wound
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes